Lisa M. Ferri is a partner in Mayer Brown’s Intellectual Property practice and serves as the IP Practice Leader for the New York Office. Lisa focuses her practice on patent and other complex intellectual property litigation with particular emphasis in the life sciences field.
Lisa has acted as trial counsel for more than 15 years, on behalf of a variety of technology companies in a number of federal district courts and the International Trade Commission. She has significant experience before appellate courts, in particular, the Federal Circuit.
Lisa’s life sciences practice spans biotechnology, pharmaceutical and medical device patent cases involving a broad range of therapeutic areas and technologies—from small molecule and biologics for the treatment of HIV/AIDS, cancer, hepatitis, influenza, auto-immunities, emesis and BPH, to drug delivery systems, recombinant DNA, RNAi and a variety of devices. Her pharmaceutical practice focuses on representing innovator companies in cases brought pursuant to the Hatch-Waxman Act. She has successfully defended a number of key blockbuster drugs. Lisa also counsels clients regarding pharmaceutical and biologics product life-cycle management and advises on the protection, enforcement and licensing of intellectual property portfolios.
Lisa is an adjunct professor of law at Fordham University School of Law, where she teaches Patent Litigation. She served as law clerk to Chief Judge Edward D. Re, U.S. Court of International Trade, who also sat by designation on a number of courts of appeal including the Federal Circuit.